StockData
DNA X, Inc. logo

DNA X, Inc. (SONM) stock

SONMNasdaqTelephone & Telegraph ApparatusFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Aug 19, 2026Score 4/30
$1.68−0.39 (-18.67%)

Close on Nov 18, 2026Market cap $2.51MP/E –Yield –

DNA X operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

DNA X's operating income for the twelve months ending Jun 30, 2026 was -$4.22M, down 213.4% year over year. For fiscal 2025 it was -$5.41M. The highest annual figure on record is $5.39M in fiscal 2018.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$5.41M–
FY2024Dec 31, 2024-$3.10M-704.3%
FY2023Dec 31, 2023$513.00K–
FY2022Dec 31, 2022-$14.29M–
FY2021Dec 31, 2021-$38.00M–
FY2020Dec 31, 2020-$29.26M–
FY2019Dec 31, 2019-$22.38M-514.9%
FY2018Dec 31, 2018$5.39M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$1.28M–
Q1 FY2026Mar 31, 2026-$3.62M–
Q4 FY2025Dec 31, 2025$4.66M-44.7%
Q3 FY2025Sep 30, 2025-$3.98M–
Q2 FY2025Jun 30, 2025-$1.47M–
Q1 FY2025Mar 31, 2025-$870.00K–
Q4 FY2024Dec 31, 2024$8.44M–
Q3 FY2024Sep 30, 2024-$2.38M-445.3%
Q2 FY2024Jun 30, 2024-$6.47M-966.1%
Q1 FY2024Mar 31, 2024-$2.69M-907.5%
Q4 FY2023Dec 31, 2023-$1.26M–
Q3 FY2023Sep 30, 2023$688.00K–
Q2 FY2023Jun 30, 2023$747.00K–
Q1 FY2023Mar 31, 2023$333.00K–
Q4 FY2022Dec 31, 2022-$1.06M–
Q3 FY2022Sep 30, 2022-$1.93M–
Q2 FY2022Jun 30, 2022-$4.22M–
Q1 FY2022Mar 31, 2022-$7.08M–
Q4 FY2021Dec 31, 2021-$11.74M–
Q3 FY2021Sep 30, 2021-$10.72M–
Q2 FY2021Jun 30, 2021-$6.49M–
Q1 FY2021Mar 31, 2021-$9.05M–
Q4 FY2020Dec 31, 2020-$7.46M–
Q1 FY2020Mar 31, 2020-$9.06M–
Q4 FY2019Dec 31, 2019-$7.40M-233.8%
Q3 FY2019Sep 30, 2019-$6.26M-290.6%
Q2 FY2019Jun 30, 2019-$4.58M-868.6%
Q1 FY2019Mar 31, 2019-$4.14M–
Q4 FY2018Dec 31, 2018$5.53M–
Q3 FY2018Sep 30, 2018$3.28M–
Q2 FY2018Jun 30, 2018$596.00K–
Q1 FY2018Mar 31, 2018-$4.01M–

More DNA X figures

See a number that looks wrong?